News Daily News Meta-analysis Teases Out What Drives Success in M-TEER Caitlin E. Cox February 10, 2026
News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
News Conference News NY Valves 2024 Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI Michael O'Riordan June 06, 2024
News Conference News NY Valves 2024 Essentials for 3D-ICE in Structural Interventions Explored in Position Statement Caitlin E. Cox June 06, 2024
Presentation EuroPCR 2024 Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial Presenter: Patrick Serruys May 15, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
Presentation EuroPCR 2024 Short Methodology Insight - LANDMARK Presenter: Davide Capodanno May 14, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News EACTS 2023 AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair Michael O'Riordan October 09, 2023
News Conference News TVT 2023 Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI Shelley Wood June 14, 2023
News Conference News TVT 2023 Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years Michael O'Riordan June 09, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023